Periostat

Rocky Mountain Spotted Fever, Acinetobacter Infections, Ureaplasma Infections + 61 more
Treatment
63 FDA approvals
20 Active Studies for Periostat

What is Periostat

DoxycyclineThe Generic name of this drug
Treatment SummaryDoxycycline is an antibiotic used to treat a wide range of bacterial infections. It is a synthetically derived version of the tetracycline family of antibiotics, with fewer side effects than the first-generation tetracyclines. Its effectiveness against specific bacteria can be determined through antibiotic susceptibility testing.
Vibramycin Hyclateis the brand name
image of different drug pills on a surface
Periostat Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Vibramycin Hyclate
Doxycycline
1967
728

Approved as Treatment by the FDA

Doxycycline, otherwise known as Vibramycin Hyclate, is approved by the FDA for 63 uses such as Trachoma and Skin Infections .
Trachoma
Skin Infections
Brucellosis
Used to treat Brucellosis in combination with Streptomycin
Recurring fever caused by Borrelia recurrentis
Granuloma Inguinale
Yaws
Campylobacter Infection
Ureaplasma Infections
Uterine Cervicitis
inhaled anthrax caused by Bacillus anthracis
Actinomycosis
Relapsing fever caused by Borrelia recurrentis
Necrotizing ulcerative gingivostomatitis
Mycoplasma Pneumoniae
Genus Chlamydia
Rectal infection
Q Fever
Vibrio Cholerae Infection
Disease
Klebsiella Infections
Bartonella bacilliformis infections
Psittacosis
Lymphogranuloma Venereum
Upper Respiratory Tract Infection
Chlamydia trachomatis
Bacteriological Techniques
Pneumococcal Infections
Calymmatobacterium granulomatis
Chancroid
Amebic colitis
Secondary Syphilis
Rickettsialpox
Urinary Tract Infection
Haemophilus ducreyi infection
Haemophilus Influenzae Infections
Communicable Diseases
Shigella Infection
Rocky Mountain Spotted Fever
Epididymo-orchitis gonococcal
Tick-borne fever
Gonorrhea
Severe Acne
Urethritis
Inclusion conjunctivitis
Urethritis
Tularemia
Tularemia
prophylaxis of Malaria
Staphylococcus (S.) Aureus Infection
Chlamydia Infections
Clostridium difficile Infection
Primary Syphilis
Typhus infections
Malaria
Bartonellosis
Acinetobacter Infections
Bacterial Infection caused by Enterobacter aerogenes
Listeriosis
Chlamydia trachomatis
Respiratory Tract Infections
Chlamydia Infections
Plague
Yersinia pestis

Effectiveness

How Periostat Affects PatientsDoxycycline and other tetracyclines stop bacteria from growing or keep them in a stationary state. They work against both gram-positive and gram-negative bacteria, and these bacteria are often resistant to tetracyclines. Doxycycline is a lipophilic drug, which means it can penetrate cells and has a wide range of effects, such as being antibacterial, antiparasitic, and anti-inflammatory. It has been used to treat skin conditions such as bullous dermatoses and rosacea.
How Periostat works in the bodyDoxycycline stops bacteria from making necessary proteins that allow them to survive and function. It does this by blocking the binding of amino acids to ribosomes, which are responsible for making proteins. Doxycycline also blocks inflammation by preventing calcium-dependent cells from forming and stopping lymphocytes from growing. It also stops an enzyme that produces a molecule that causes inflammation.

When to interrupt dosage

The prescribed dose of Periostat is reliant upon the diagnosed condition, such as Urethritis, Chlamydia trachomatis and Respiratory Tract Infections. The measure of dosage differs, in accordance with the method of delivery (e.g. Capsule or Syrup - Oral) featured in the table underneath.
Condition
Dosage
Administration
Recurring fever caused by Borrelia recurrentis
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
Q Fever
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
Plague
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
Rickettsialpox
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
Actinomycosis
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
Rosacea
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
Urethritis
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
inhaled anthrax caused by Bacillus anthracis
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
Urinary Tract Infection
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
Necrotizing ulcerative gingivostomatitis
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
Shigella Infection
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
Typhus infections
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
Malaria
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
Clostridium difficile Infection
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
Klebsiella Infections
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
Gonorrhea
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
Calymmatobacterium granulomatis
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
Chlamydia trachomatis
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
Campylobacter Infection
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous
Secondary Syphilis
10.0 mg/mL, , 75.0 mg, 100.0 mg, 150.0 mg, 50.0 mg, 200.0 mg, 20.0 mg, 1.0 mg/mg, 40.0 mg, 5.0 mg/mg, 7.5 mg/mg, 25.0 mg/mL, 50.0 mg/mL, 120.0 mg, 60.0 mg, 0.1 mg/mg, 5.0 mg/mL, 8.8 %, 20.0 mg/mL, 0.75 mg/mg, 0.5 mg/mg, 80.0 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Kit - Oral, Capsule, extended release, Capsule, extended release - Oral, Powder, Powder - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Syrup, Syrup - Oral, For suspension, For suspension - Oral, Gel - Oral, Suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Oral; Topical, Capsule - Oral; Topical, Injection, powder, for solution, Injection, powder, for solution - Intravenous

Warnings

Periostat has three contraindications and should not be ingested when any of the conditions mentioned in the table below are present.Periostat Contraindications
Condition
Risk Level
Notes
Pulse Frequency
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Doxycycline may interact with Pulse Frequency
Severe Hypersensitivity Reactions
Do Not Combine
Doxycycline may interact with Pulse Frequency
There are 20 known major drug interactions with Periostat.
Common Periostat Drug Interactions
Drug Name
Risk Level
Description
Abemaciclib
Major
The metabolism of Abemaciclib can be decreased when combined with Doxycycline.
Acalabrutinib
Major
The metabolism of Acalabrutinib can be decreased when combined with Doxycycline.
Alectinib
Major
The metabolism of Alectinib can be decreased when combined with Doxycycline.
Alpelisib
Major
The metabolism of Alpelisib can be decreased when combined with Doxycycline.
Amdinocillin
Major
The therapeutic efficacy of Amdinocillin can be decreased when used in combination with Doxycycline.
Periostat Toxicity & Overdose RiskThe toxic dose of doxycycline in rats is 2000mg/kg, 1870mg/kg in mice, and 500mg/kg in dogs. If an overdose happens, doxycycline should be stopped and supportive medical care should be given. Dialysis will not reduce the amount of the drug in the body and is not recommended for overdoses.
image of a doctor in a lab doing drug, clinical research

Periostat Novel Uses: Which Conditions Have a Clinical Trial Featuring Periostat?

34 ongoing studies are examining the potential of Periostat to combat Haemophilus Influenzae Infections, Respiratory Tract Infections and Amebic Colitis.
Condition
Clinical Trials
Trial Phases
Psittacosis
0 Actively Recruiting
Uterine Cervicitis
0 Actively Recruiting
Listeriosis
0 Actively Recruiting
Malaria
0 Actively Recruiting
Secondary Syphilis
0 Actively Recruiting
Urethritis
0 Actively Recruiting
Yaws
0 Actively Recruiting
Brucellosis
0 Actively Recruiting
Inclusion conjunctivitis
0 Actively Recruiting
Necrotizing ulcerative gingivostomatitis
0 Actively Recruiting
Chlamydia Infections
0 Actively Recruiting
Genus Chlamydia
0 Actively Recruiting
Disease
0 Actively Recruiting
Q Fever
0 Actively Recruiting
Rickettsialpox
0 Actively Recruiting
Urethritis
0 Actively Recruiting
Shigella Infection
2 Actively Recruiting
Phase 2, Phase 1
Bartonella bacilliformis infections
0 Actively Recruiting
Tularemia
0 Actively Recruiting
Bacterial Infection caused by Enterobacter aerogenes
0 Actively Recruiting

Periostat Reviews: What are patients saying about Periostat?

5Patient Review
2/8/2010
Periostat for Inflammation of the Gums and Mouth
I am a smoker with moderate to advanced periodontal disease. My periodontist performed scaling and root planning with localized surgical treatment. After several years in maintenance my condition began to breakdown. I began using periostat and slowly over the next nine months the periodontist noted a decrease in my bleeding and inflammation as well as my pocket depths. This medication has worked from inside my body to help control the inflammation response to my periodontal infection.
2.3Patient Review
3/10/2010
Periostat for Inflammation of the Gums and Mouth
Since having a hysterectomy (not related to periostat), I've been having some serious digestive issues. Bloating, gas, indigestion; the works. I'm currently taking glutamine and probiotics, but I'm not sure if it's the medicine or not. I was on it for years before this happened, and the package did have warnings about long term use.
1Patient Review
10/24/2008
Periostat for Additional Medication for Inflammation Around the Teeth
After having some dental work done, my dentist prescribed this medication. However, I had to stop taking it because it resulted in blood in my stool. I also had to stop taking other medications (simvastatin, baby aspirin and Chantix) until the condition clears up.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about periostat

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How long should you use Periostat?

"PERIOSTAT is meant to be used for treatment periods of 3 months. It shouldn't be used for more than 3 consecutive three-month periods. There's no need to change the dosage for elderly patients."

Answered by AI

Is Periostat the same as doxycycline?

"Periostat is a drug used to help reduce pocket depth and promote attachment level gain in patients with adult periodontitis. The dosage of Periostat is different from that of doxycycline, which is used to treat infections."

Answered by AI

What is Periostat used for?

"Periostat is used to treat periodontitis, a condition that affects the gums and can cause teeth to become loose or fall out. The standard treatment for periodontitis is scaling and root planing, which is done by a dentist or dental hygienist."

Answered by AI

What is Periostat periodontics?

"Periostat is an orally administered tablet that contains a novel formulation of 23.08mg doxycycline hyclate. It is designed to be taken twice a day as an adjunct to scaling and root planing (SRP), and has been shown to increase clinical attachment level gain and reduce probing depths in patients with chronic periodontitis."

Answered by AI

Clinical Trials for Periostat

Have you considered Periostat clinical trials? We made a collection of clinical trials featuring Periostat, we think they might fit your search criteria.
Have you considered Periostat clinical trials? We made a collection of clinical trials featuring Periostat, we think they might fit your search criteria.
Have you considered Periostat clinical trials? We made a collection of clinical trials featuring Periostat, we think they might fit your search criteria.